Wendy Oakden1, Nicholas A Bock2, Alia Al-Ebraheem3, Michael J Farquharson3, and Greg J Stanisz1,4,5
1Physical Sciences, Sunnybrook Research Institute, Toronto, ON, Canada, 2Psychology, Neuroscience and Behavior, McMaster University, Hamilton, ON, Canada, 3Medical Physics and Applied Radiation Sciences, McMaster University, Hamilton, ON, Canada, 4Medical Biophysics, University of Toronto, Toronto, ON, Canada, 5Neurosurgery and Pediatric Neurosurgery, Medical University of Lublin, Lublin, Poland
Synopsis
The cuprizone mouse model of demyelination is widely used. While initial
histological studies in rats reported only spongiform encephalopathy, more
recent work has also demonstrated demyelination. In this study we use a high-resolution
myelin-contrast optimized MRI protocol to identify regions of altered myelin content
in the rat brain. Wistar rats were imaged after 2, 4, and 6 weeks on a
cuprizone diet. Luxol fast blue was used to assess demyelination, and X-Ray
fluorescence for quantification of transition metals which also affect MRI
contrast. This study demonstrates that
cuprizone-induced demyelination in the rat brain can be observed in vivo using MRI.Purpose
While cuprizone induces a well-established model of
demyelination in the mouse, much less is known about the effects of cuprizone
on rat brain. It would be advantageous to have a rat model of cuprizone induced
demyelination for MRI
studies as the white matter structures are more substantial in
that species. Additionally, while several different
quantitative MRI methods exist for assessing myelin, the very small
size of the mouse brain can pose a problem for techniques like
quantitative T2 which are affected by the process of diffusion at ultra-high
resolution
1. The rat model may also be
desirable in comparing behavioural data with MRI. Initial histological studies in
rats reported spongiform encephalopathy or intrymyelinic edema with no loss of
myelin
2,3,4, while more recent histological work has demonstrated demyelination in rat brain
5. The goal of this study is to characterize a
rat model of cuprizone induced demyelination using MRI for the first time, and validate this using luxol fast blue (LFB) to assess demyelination, and X-Ray fluorescence to quantify changes in transition metals which also affect MRI contrast.
Methods
16-week old male Wistar rats were fed either a 1% cuprizone-enriched
diet (treated) or normal rat chow (control) ad libitum. 5 treated and 5
control animals were sacrificed after 4 weeks, brains removed and frozen for
metal quantification. 6 treated and 2 control animals were imaged after 2, 4,
or 6 weeks with a 7T Bruker BioSpec MRI. Following MRI, animals were perfused
with 10% formalin, brains removed and embedded in paraffin. 5 and 10 µm sections
were stained with H&E and LFB respectively.
T1-weighted images optimized for myelin contrast6 consisted of an MP-RAGE
sequence with TE 2.3 ms, TR 5.9 s, 4 segments with duration 384 ms, inversion
time 1.3 s, 2 averages, FA 12º, and 167um isotropic resolution. PD-weighted images were acquired at the same resolution using a FLASH
sequence with TE 2.3ms, TR 12.3ms, 6 averages, and FA 6º.
Ratio images were calculated by dividing the MP-RAGE by the
PD-weighted images and normalizing by the signal in muscle in the head. 2 rats per group (Control Week 2, Treated
Week 2, 4, and 6) were spatially registered to a common template using FLIRT
and FNIRT with FSL Version 5.07.
ROI measurements were made in the corpus callosum (CC), deep cerebellar white
matter (DCW), and cerebellar nuclei (CN).
Transition metals (iron, manganese, copper and zinc) were
quantified in ROIs representing the DCW and CN in sections from 5 4-week
control and 4-week treated animals. Metals
were quantified using X-Ray fluorescence (XRF) at the Canadian Light Source
(CLS) in Saskatoon using the VESPERS (Very powerful Elemental and Structural
Probe Employing Radiation from a Synchrotron) beamline.
Results
Ratio images at each timepoint were combined for display.
Figure 1 shows a transverse slice through the corpus callosum (top) and
cerebellum (bottom) for the control animals at 2 weeks and in cuprizone treated
animals at 2, 4, and 6 weeks. The signal in CC and DCW does not decrease,
however a marked decrease in signal is evident in the CN. This signal decrease
can be quantified relative to the signal in muscle (Fig. 2).
Corresponding H&E and LFB stained sections (Fig. 3) show
that the changes in CN are due to a combination of spongiform encephalopathy and
loss of myelin.
The XRF measurements revealed significant (p<0.01)
reductions in iron and copper in the CN of treated rats. No significant changes in zinc or manganese
were noted in the CN and there were no changes in any transition metals in the
DCW.
Discussion and Conclusions
High resolution myelin-contrast optimized MR images allowed the changes in rat
brain due to cuprizone diet to be observed
in vivo, and were correlated with changes observed on histology. Unlike the
mouse model, which shows widespread demyelination throughout the brain, the
demyelination we observed in the rat was highly localized to the cerebellar
nuclei. The timing of the diet, amount of cuprizone, and strain of rat or mouse
are all known to affect the degree of demyelination, and varying these parameters
may also alter the pattern of demyelination. Histologic validation of this
imaging technique in cuprizone rat model of demyelination will allow us to
optimize the diet and timing of experiments using far fewer animals than with
histology alone.
The decrease in copper in the cerebellar nuclei is consistent with the idea
that cuprizone chelates copper, which leads to demyelination.
Acknowledgements
No acknowledgement found.References
1. Oakden W,
Stanisz GJ. Effects of diffusion on high-resolution quantitative T2 MRI. NMR
Biomed. 2014;27(6):672–680.
2. Carlton WW. Spongiform encephalopathy
induced in rats and guinea pigs by cuprizone. Exp. Mol. Pathol.
1969;10(3):274–287.
3. Love S. Cuprizone neurotoxicity in the
rat: morphologic observations. J. Neurol. Sci. 1988;84(2-3):223–237.
4. Matsushima GK, Morell P. The
neurotoxicant, cuprizone, as a model to study demyelination and remyelination
in the central nervous system. Brain Pathol. 2001;11(1):107–116.
5. Adamo AM, Paez PM, Escobar Cabrera OE, et al. Remyelination after
cuprizone-induced demyelination in the rat is stimulated by apotransferrin.
Exp. Neurol. 2006;198(2):519–529.
6. Bock NA, Hashim E, Janik R, et al. Optimizing T1-weighted imaging of
cortical myelin content at 3.0 T. Neuroimage. 2013;65:1–12.
7. M. Jenkinson, C.F. Beckmann, T.E.
Behrens, M.W. Woolrich SMS. FSL. Neuroimage. 2012;62:782-790.